IRMD
Iradimed
$81.87
−$1.69 (−2.02%)Sep 10, 2026
Key metrics
The numbers that frame IRMD today
- Market cap
- $1.05B
- P/E (TTM)
- 45.4
- EV / FCF
- 40.2
- Gross margin
- 75.9%
- EV / Sales
- 11.4
- ROIC
- 69.2%
- Div yield
- 1.51%
- Debt / equity
- 0.0
- 52wk Low
- $66.90
- 52wk High
- $107.19
Growth
Revenue and earnings trend for IRMD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IRMD
Is Iradimed a good buy?
Yes. Iradimed has excellent quality, and it outweighs the weak momentum here. Growth looks strong, which supports the long-term business case. We think Iradimed is selling at a fair price.
What is the market capitalization of IRMD?
Iradimed's market capitalization is $1.05B.
What is the P/E ratio for IRMD stock?
Iradimed's current P/E ratio is 45.4.
What is the 52-week high for IRMD stock?
The 52-week high for Iradimed is $107.19. The current close of $81.87 is 23.6% below that high.
What is the 52-week low for IRMD stock?
The 52-week low for Iradimed is $66.90. The current close of $81.87 is 22.4% above that low.
Does IRMD stock pay dividends?
Iradimed pays a dividend. The latest dividend per share in the company data is $1.24, which implies a yield of 1.51% based on the current close.
What is the Debt / Equity ratio for IRMD?
Iradimed's Debt / Equity ratio is 0.